RxDoctor Payments Data

Rosa Gonzalez

Child & Adolescent Psychiatry · Beaumont, TXNPI 1306199385

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 299 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.3% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,414 and has fallen 58.2% since, to $592 in 2025. Among child & adolescent psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,924in general payments, 2019–2025

Across 299 payments — averaging $23.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
  • AbbVie$740
  • Takeda Pharmaceuticals U.S.A., Inc.$682
  • Sunovion Pharmaceuticals Inc.$657
  • Corium, LLC$527
  • Otsuka America Pharmaceutical, Inc.$468
  • plus $3K from 13 others
$47,783in research payments, 2019–2025

Across 7 payments — averaging $6826.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$48K

What the payments were for

  • Food & beverage$6,83699%
  • Education$881%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,924 in reported general payments places this provider in the 95th percentile of 301 child & adolescent psychiatry providers in Texas.

See all child & adolescent psychiatry providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Aripiprazole28$3,306
Clorazepate Dipotassium18$1,897
Ziprasidone Hcl17$1,673
Bupropion XlBupropion Hcl46$703
Alprazolam46$589
Risperidone15$534
Fluoxetine Hcl59$526
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine12$458
Duloxetine Hcl34$449
Benztropine Mesylate20$432
Venlafaxine Hcl ErVenlafaxine Hcl30$417
Buspirone Hcl29$380
Sertraline Hcl18$358
Methylphenidate Hcl15$323
Diazepam49$253

Paid to pharmacies, not to this prescriber.

Other child & adolescent psychiatry in Beaumont

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →